Insights into product and process related challenges of lentiviral vector bioprocessing
Biotechnology and Bioengineering · 2024-08 · 121 (8) · 2466-2481
DOI: 10.1002/bit.28498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023-08. Verfasst von Christopher Perry und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Engineering, University College London, London, UK. Hauptthemen laut MEDLINE: Lentivirus, Genetic Vectors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI Engineering and Physical Sciences Research Council, Centre for Doctoral Training at the Department of Biochemical Engineering, Doctoral Training Partnership at UCL.
Abstract (Originalsprache)
Lentiviral vectors (LVs) are used in advanced therapies to transduce recipient cells for long term gene expression for therapeutic benefit. The vector is commonly pseudotyped with alternative viral envelope proteins to improve tropism and is selected for enhanced functional titers. However, their impact on manufacturing and the success of individual bioprocessing unit operations is seldom demonstrated. To the best of our knowledge, this is the first study on the processability of different Lentiviral vector pseudotypes. In this work, we compared three envelope proteins commonly pseudotyped with LVs across manufacturing conditions such as temperature and pump flow and across steps common to downstream processing. We have shown impact of filter membrane chemistry on vector recoveries with differing envelopes during clarification and observed complete vector robustness in high shear manufacturing environments using ultra scale‐down technologies. The impact of shear during membrane filtration in a tangential flow filtration‐mimic showed the benefit of employing higher shear rates, than currently used in LV production, to increase vector recovery. Likewise, optimized anion exchange chromatography purification in monolith format was determined. The results contradict a common perception that lentiviral vectors are susceptible to shear or high salt concentration (up to 1.7 M). This highlights the prospects of improving LV recovery by evaluating manufacturing conditions that contribute to vector losses for specific production systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Engineering, University College London, London, UK.
- Division of Infection and Immunology, University College London, London, UK.
- Biotherapeutics and Advanced Therapies, Scientific Research and Innovation, Medicines and Healthcare Products Regulatory Agency, South Mimms, Potters Bar, UK.
Förderung
- UKRI Engineering and Physical Sciences Research Council
- Centre for Doctoral Training at the Department of Biochemical Engineering
- Doctoral Training Partnership at UCL
- National Institute for Biological Standards and Control (NIBSC)-Medicines and Healthcare Products Regulatory Agency (MHRA)
Zitieren
APA
Perry, C., Mujahid, N., Takeuchi, Y., & Rayat, A. C. M. E. (2024). Insights into product and process related challenges of lentiviral vector bioprocessing. Biotechnology and Bioengineering, 121(8), 2466-2481. https://doi.org/10.1002/bit.28498
Vancouver
Perry C, Mujahid N, Takeuchi Y, Rayat ACME. Insights into product and process related challenges of lentiviral vector bioprocessing. Biotechnology and Bioengineering. 2024;121(8):2466-2481. doi:10.1002/bit.28498
BibTeX
@article{Perry2024,
author = {Perry, Christopher and Mujahid, Noor and Takeuchi, Yasu and Rayat, Andrea C M E},
title = {Insights into product and process related challenges of lentiviral vector bioprocessing},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {8},
pages = {2466--2481},
doi = {10.1002/bit.28498}
}
EUVIMED